Albemarle - ALB Stock Forecast, Price & News

20 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Albemarle in the last year. There are currently 2 sell ratings, 8 hold ratings and 10 buy ratings for the stock. The consensus among Wall Street analysts is that investors should "hold" ALB shares. A hold rating indicates that analysts believe investors should maintain any existing positions they have in ALB, but not buy additional shares or sell existing shares.
View ALB analyst ratings or view top-rated stocks.

20 equities research analysts have issued 12-month price objectives for Albemarle's shares. Their ALB share price forecasts range from $155.00 to $498.00. On average, they anticipate the company's stock price to reach $308.00 in the next twelve months. This suggests a possible upside of 41.4% from the stock's current price.
View analysts price targets for ALB or view top-rated stocks among Wall Street analysts.

Albemarle's stock was trading at $216.86 on January 1st, 2023. Since then, ALB stock has increased by 0.4% and is now trading at $217.79.
View the best growth stocks for 2023 here.

Albemarle saw a increase in short interest in February. As of February 28th, there was short interest totaling 5,340,000 shares, an increase of 32.2% from the February 13th total of 4,040,000 shares. Based on an average daily trading volume, of 1,560,000 shares, the days-to-cover ratio is currently 3.4 days.
View Albemarle's Short Interest.

The company is scheduled to release its next quarterly earnings announcement on Wednesday, May 3rd 2023.
View our ALB earnings forecast.

Albemarle Co. (NYSE:ALB) announced its quarterly earnings data on Thursday, February, 16th. The specialty chemicals company reported $8.62 earnings per share for the quarter, beating the consensus estimate of $8.46 by $0.16. The specialty chemicals company had revenue of $2.62 billion for the quarter, compared to analysts' expectations of $2.60 billion. Albemarle had a trailing twelve-month return on equity of 37.63% and a net margin of 36.75%. Albemarle's revenue for the quarter was up 193.1% on a year-over-year basis. During the same period in the previous year, the company posted $1.01 earnings per share.
Read the conference call transcript.

Albemarle announced a quarterly dividend on Thursday, February 23rd. Shareholders of record on Friday, March 17th will be paid a dividend of $0.40 per share on Monday, April 3rd. This represents a $1.60 annualized dividend and a dividend yield of 0.73%. The ex-dividend date of this dividend is Thursday, March 16th. This is a boost from the stock's previous quarterly dividend of $0.40.
Read our dividend analysis for ALB.

ETFs with the largest weight of Albemarle (NYSE:ALB) stock in their portfolio include Global X Lithium & Battery Tech ETF (LIT), First Trust NASDAQ Clean Edge Green Energy Index Fund (QCLN), VanEck Green Metals ETF (GMET), iShares Environmental Infrastructure and Industrials ETF (EFRA), Optica Rare Earths & Critical Materials ETF (CRIT), ALPS Clean Energy ETF (ACES), ProShares S&P Global Core Battery Metals ETF (ION) and KraneShares Electric Vehicles and Future Mobility Index ETF (KARS).

Albemarle (NYSE:ALB) pays an annual dividend of $1.60 per share and currently has a dividend yield of 0.74%. The company has been increasing its dividend for 30 consecutive years, indicating the company has a strong committment to maintain and grow its dividend. The dividend payout ratio is 7.01%. This payout ratio is at a healthy, sustainable level, below 75%. Based on earnings estimates, ALB will have a dividend payout ratio of 5.84% next year. This indicates that the company will be able to sustain or increase its dividend.
Read our dividend analysis for ALB.

Albemarle issued an update on its FY23 earnings guidance on Wednesday, February, 15th. The company provided EPS guidance of $26.00-33.00 for the period, compared to the consensus earnings per share estimate of $29.00. The company issued revenue guidance of $11.3-12.9 billion, compared to the consensus revenue estimate of $11.33 billion.

63 employees have rated Albemarle Chief Executive Officer Luther C. Kissam, IV on Glassdoor.com. Luther C. Kissam, IV has an approval rating of 75% among the company's employees.

Based on aggregate information from My MarketBeat watchlists, some companies that other Albemarle investors own include Intact Financial (IFC), Constellation Software (CSU), AutoCanada (ACQ), Alimentation Couche-Tard (ATD.B), AbbVie (ABBV), Vermilion Energy (VET), Wheaton Precious Metals (WPM), NVIDIA (NVDA), Rogers Communications (RCI) and Alibaba Group (BABA).

Albemarle trades on the New York Stock Exchange (NYSE) under the ticker symbol "ALB."

Albemarle's stock is owned by a number of retail and institutional investors. Top institutional investors include Moneta Group Investment Advisors LLC (89.21%), Franklin Resources Inc. (2.56%), Baillie Gifford & Co. (2.31%), Geode Capital Management LLC (2.02%), Bank of America Corp DE (1.52%) and Mirae Asset Global Investments Co. Ltd. (1.34%). Insiders that own company stock include Eric Norris, J Kent Masters, John Clarence Barichivich III, Karen G Narwold, Karen G Narwold, Luther C Iv Kissam, Netha N Johnson, Raphael Goszcz Crawford and Scott Tozier.
View institutional ownership trends.

Shares of ALB stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

One share of ALB stock can currently be purchased for approximately $217.79.

Albemarle (NYSE:ALB) has a market capitalization of $25.55 billion and generates $7.32 billion in revenue each year. The specialty chemicals company earns $2.69 billion in net income (profit) each year or $22.82 on an earnings per share basis.

The company employs 7,400 workers across the globe.

Albemarle's mailing address is 4250 CONGRESS STREET SUITE 900, CHARLOTTE NC, 28209. The official website for the company is www.albemarle.com. The specialty chemicals company can be reached via phone at (980) 299-5700, via email at invest@albemarle.com, or via fax at 225-388-7686.